Skip to main content
. 2019 May 6;19:33. doi: 10.1186/s12894-019-0453-9

Fig. 3.

Fig. 3

Overall survival in pT3 or higher stage prostate cancer. DDR pathway alteration was associated with a shorter overall survival in patients with pT3 or higher stage prostate cancer